These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24785843)

  • 1. Cost-benefit analysis of indirect antiglobulin screening in Rh(D)-negative women at 28 weeks of gestation.
    Abbey R; Dunsmoor-Su R
    Obstet Gynecol; 2014 May; 123(5):938-945. PubMed ID: 24785843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost matters.
    Werner EF
    Obstet Gynecol; 2014 May; 123(5):919-920. PubMed ID: 24785839
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
    Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
    BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation.
    Horvath S; Wang L; Calo W; Yazer MH
    Contraception; 2024 Nov; 139():110530. PubMed ID: 38906503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.
    Saramago P; Yang H; Llewellyn A; Palmer S; Simmonds M; Griffin S
    BJOG; 2018 Oct; 125(11):1414-1422. PubMed ID: 29415334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
    Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M
    Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and benefits of non-invasive fetal RhD determination.
    Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the management of Rh-Rh incompatibility with noninvasive fetal Rh genotyping for targeted prophylaxis cost-effective in the Turkish population?
    Demirel E; Kelekçi S; Ekmekci E; Şengül M; İri R; Atasever M
    Turk J Med Sci; 2018 Feb; 48(1):1-4. PubMed ID: 29479934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.
    Hawk AF; Chang EY; Shields SM; Simpson KN
    Obstet Gynecol; 2013 Sep; 122(3):579-85. PubMed ID: 23921866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.
    Pilgrim H; Lloyd-Jones M; Rees A
    Health Technol Assess; 2009 Feb; 13(10):iii, ix-xi, 1-103. PubMed ID: 19210896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    Crowther CA; Middleton P; McBain RD
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.
    Int J Gynaecol Obstet; 1999 Jul; 66(1):63-70. PubMed ID: 10458556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the management of rh-negative pregnant women.
    Duplantie J; Gonzales OM; Bois A; Nshimyumukiza L; Gekas J; Bujold E; Morin V; Vallée M; Giguère Y; Gagné C; Rousseau F; Reinharz D
    J Obstet Gynaecol Can; 2013 Aug; 35(8):730-740. PubMed ID: 24007709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect antiglobulin test and anti-D prophylaxis in hereditary persistence of fetal hemoglobin.
    Fadel HE; Krauss JS
    Obstet Gynecol; 1986 Mar; 67(3 Suppl):13S-14S. PubMed ID: 2418396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New laboratory procedures and Rh blood type changes in a pregnant woman.
    Sandler SG; Li W; Langeberg A; Landy HJ
    Obstet Gynecol; 2012 Feb; 119(2 Pt 2):426-428. PubMed ID: 22270426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.